Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Monkey hybrid stem cells develop cellular features of Huntington's disease.

Laowtammathron C, Cheng ECh, Cheng PH, Snyder BR, Yang SH, Johnson Z, Lorthongpanich C, Kuo HC, Parnpai R, Chan AW.

BMC Cell Biol. 2010 Feb 5;11:12. doi: 10.1186/1471-2121-11-12.

2.

Reprogramming Huntington monkey skin cells into pluripotent stem cells.

Chan AW, Cheng PH, Neumann A, Yang JJ.

Cell Reprogram. 2010 Oct;12(5):509-17. doi: 10.1089/cell.2010.0019.

3.

Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.

Carter RL, Chen Y, Kunkanjanawan T, Xu Y, Moran SP, Putkhao K, Yang J, Huang AH, Parnpai R, Chan AW.

Stem Cell Reports. 2014 Oct 14;3(4):585-93. doi: 10.1016/j.stemcr.2014.07.011. Epub 2014 Sep 4.

4.

Pluripotent hybrid stem cells from transgenic Huntington's disease monkey.

Laowtammathron C, Chan AW.

Methods Mol Biol. 2013;1010:61-77. doi: 10.1007/978-1-62703-411-1_5.

PMID:
23754219
5.

Derivation of Huntington's disease-affected human embryonic stem cell lines.

Bradley CK, Scott HA, Chami O, Peura TT, Dumevska B, Schmidt U, Stojanov T.

Stem Cells Dev. 2011 Mar;20(3):495-502. doi: 10.1089/scd.2010.0120. Epub 2010 Aug 31.

PMID:
20649476
6.

Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.

Dong X, Zong S, Witting A, Lindenberg KS, Kochanek S, Huang B.

J Gene Med. 2012 Jul;14(7):468-81. doi: 10.1002/jgm.2641.

PMID:
22700462
7.

Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease.

Putkhao K, Kocerha J, Cho IK, Yang J, Parnpai R, Chan AW.

Stem Cells Dev. 2013 Apr 15;22(8):1198-205. doi: 10.1089/scd.2012.0469. Epub 2013 Jan 15.

8.

Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.

Lorincz MT, Zawistowski VA.

Mol Cell Neurosci. 2009 Jan;40(1):1-13. doi: 10.1016/j.mcn.2008.06.004. Epub 2008 Jun 19.

9.

Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.

Jiang M, Wang J, Fu J, Du L, Jeong H, West T, Xiang L, Peng Q, Hou Z, Cai H, Seredenina T, Arbez N, Zhu S, Sommers K, Qian J, Zhang J, Mori S, Yang XW, Tamashiro KL, Aja S, Moran TH, Luthi-Carter R, Martin B, Maudsley S, Mattson MP, Cichewicz RH, Ross CA, Holtzman DM, Krainc D, Duan W.

Nat Med. 2011 Dec 18;18(1):153-8. doi: 10.1038/nm.2558.

10.

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.

Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martín-Ibañez R, Muñoz MT, Mengod G, Ernfors P, Alberch J.

J Neurosci. 2004 Sep 1;24(35):7727-39.

11.

Huntingtin and its role in neuronal degeneration.

Li SH, Li XJ.

Neuroscientist. 2004 Oct;10(5):467-75. Review.

PMID:
15359012
12.

Induced Pluripotent HD Monkey Stem Cells Derived Neural Cells for Drug Discovery.

Kunkanjanawan T, Carter R, Ahn KS, Yang J, Parnpai R, Chan AWS.

SLAS Discov. 2017 Jul;22(6):696-705. doi: 10.1177/2472555216685044. Epub 2016 Dec 27.

PMID:
28027448
13.

Germline transmission in transgenic Huntington's disease monkeys.

Moran S, Chi T, Prucha MS, Ahn KS, Connor-Stroud F, Jean S, Gould K, Chan AW.

Theriogenology. 2015 Jul 15;84(2):277-85. doi: 10.1016/j.theriogenology.2015.03.016. Epub 2015 Mar 25.

14.

Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.

Valencia A, Reeves PB, Sapp E, Li X, Alexander J, Kegel KB, Chase K, Aronin N, DiFiglia M.

J Neurosci Res. 2010 Jan;88(1):179-90. doi: 10.1002/jnr.22184.

PMID:
19642201
15.

Large Animal Models of Huntington's Disease.

Li XJ, Li S.

Curr Top Behav Neurosci. 2015;22:149-60. doi: 10.1007/7854_2013_246. Review.

16.

Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease.

Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ.

Hum Mol Genet. 2008 Sep 1;17(17):2738-51. doi: 10.1093/hmg/ddn175. Epub 2008 Jun 16.

17.

Multiple phenotypes in Huntington disease mouse neural stem cells.

Ritch JJ, Valencia A, Alexander J, Sapp E, Gatune L, Sangrey GR, Sinha S, Scherber CM, Zeitlin S, Sadri-Vakili G, Irimia D, Difiglia M, Kegel KB.

Mol Cell Neurosci. 2012 May;50(1):70-81. doi: 10.1016/j.mcn.2012.03.011. Epub 2012 Apr 6.

18.
20.

Expression of the Huntington's disease transgene in neural stem cell cultures from R6/2 transgenic mice.

Chu-LaGraff Q, Kang X, Messer A.

Brain Res Bull. 2001 Oct-Nov 1;56(3-4):307-12.

PMID:
11719265

Supplemental Content

Support Center